Amyris (AMRS) Misses Q1 EPS by 21c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Amyris Reports First Quarter 2015 Financial Results
May 5, 2015 4:00 PM EDTTotal first-quarter 2015 non-GAAP cash revenue inflows of $30.3 million, compared with $17.9 million for first quarter of 2014 Total first-quarter 2015 revenues of $7.9 million, an increase of 30% compared with same quarter last year Total first-quarter 2015 combined research & development and sales, general & administrative expenses of $26.4 million, essentially flat compared with first quarter of 2014 Cash, cash equivalents and short-term investments of $44.9 million at March 31, 2015, an increase from $43.4 million at December 31, 2014.
EMERYVILLE, Calif., May 5, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq: AMRS), the industrial bioscience company, today announced financial results for the first... More
